NASDAQ · Drug Manufacturers - Specialty & Generic

LFCR (LFCR) Stock

$4.34 +0.23% NASDAQ: LFCR Healthcare

Valuation

MetricValue
Price$4.34
Market Cap$162.79M
P/E Ratio-3.77
P/B Ratio179.67
P/S Ratio1.22
EPS (TTM)$-1.27
52-Week High$8.98
52-Week Low$3.63
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3900.00%
ROA-16.32%
ROCE-1700.00%
Gross Margin-13.18%
Operating Margin-13.18%
Net Margin-25.22%
Debt/Equity7.23
Current Ratio2.87

Annual Financials (USD)

Metric20212022202320242025
Revenue$101.0M$111.0M$103.0M$128.0M$129.0M
Operating Profit$-9.0M$-12.0M$-22.0M$-9.0M$-17.0M
Net Profit$-32.0M$-117.0M$-100.0M$12.0M$-39.0M
EPS$-1.12$-3.97$-3.32$0.33$-1.27
Op Margin-8.8%-10.6%-21.1%-6.9%-13.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$503.0M$275.0M$254.0M$254.0M$239.0M
Total Liabilities$300.0M$187.0M$258.0M$243.0M$238.0M
Cash$1.0M$1.0M$19.0M$8.0M$8.0M
Borrowings$216.0M$248.0M$113.0M$134.0M$131.0M

Latest News

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jul 15, 2026 Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market Insider Monkey · Jul 15, 2026 Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations? Insider Monkey · Jun 30, 2026 Barrington Adjusts Price Target on Lifecore Biomedical to $6.50 From $6, Maintains Outperform Rating MT Newswires · Jun 16, 2026 Lifecore Biomedical Signs Deal to Support Manufacturing of Neurology Injection Product MT Newswires · Jun 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$16.0M$-23.0M$-17.0M$0$0
Investing Cash Flow$-38.0M$50.0M$-26.0M$-37.0M$-20.0M
Financing Cash Flow$-11.0M$-2.0M$-6.0M$5.0M$1.0M
Net Cash Flow$1.0M$0$17.0M$-11.0M$0
Free Cash Flow$-9.0M$-53.0M$-39.0M$-18.0M$-14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield6.34%
Quick Ratio2.41
Interest Coverage-0.77
Return 1Y-43.57%
Return 3Y-53.25%
Return 5Y-59.95%

Ownership

Insiders Held2.83%
Institutions Held77.25%
Institutions Float Held79.50%
Institutional HolderSharesReport Date
WYNNEFIELD CAPITAL INC4,703,2162026-03-31
Legion Partners Asset Management, LLC4,461,8232026-03-31
Greenhaven Road Investment Management, L.p.3,537,5732026-03-31
325 Capital Llc2,162,4662026-03-31
Blackrock Inc.1,877,3052026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACB $2.72 -0.73% 115.33 $168.48M 0.00%
ACHV $6.66 +2.94% -4.63 $683.71M 0.00%
BIOA $20.88 -4.09% -9.34 $786.12M 0.00%
CGC $0.92 +4.02% -0.20 $390.20M 0.00%
CVRX $4.88 +2.95% -2.98 $129.50M 0.00%

About LFCR

LFCR is led by CEO Paul Josephs, publicly traded since 1996.

LFCR stock trades at $4.34 with a market capitalization of $162.79M. The stock is valued at a price-to-earnings (P/E) ratio of -3.77, price-to-book of 179.67, price-to-sales of 1.22. Over the past 52 weeks the stock has ranged between $3.63 and $8.98, and currently trades 51.7% below its 52-week high.

On profitability, LFCR generates a return on equity (ROE) of -3900.00%, return on capital employed of -1700.00%, an operating margin of -13.18%, a net profit margin of -25.22%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides